Tech Offer
-
2,3-Dihydro-5H-1,4-benzodiheteroepin-3-yl) purines with antitumour activity that find application in the treatment of tumours in animals and humans, as well as a method for the preparation of the compounds ...
-
AUTHOR: Garrido, JM; Sánchez-Montesinos, I. REGISTRY NO.: P200930321. PCT/ES2010/070403 PRIORITY DATE: 16/06/2009 HOLDER: University of Granada / Andalusian Public Health SystemSUMMARY: SUMMARY: A composition comprising ...
-
The present invention provides a series of squaramide-based compounds as antiparasitic agents for the treatment of leishmaniasis and Chagas disease in particular. For the preparation of a medicinal product for ...
-
Automated software that assesses pressure using infrared (IR) of a piece of writing, drawing, etc. By means of an IR sensor that enables the capture of both visible light and ...
-
Application number: P201631327Application date: 14/10/2016PCT International Application No: PCT/ES2017/070680International application filing date: 13/10/2017Holding entities: University of Granada and Servicio Andaluz ...
-
Bacterial exopolysaccharide for use in therapeutics for leukaemia
-
Patent No.: ES2161638 Priority date: 14.01.2000
-
These tests detect in rodents, in a maximum period of a week, the harmful or rewarding effect of any substance or agent consumed or received.
-
Fecha de prioridad: 26/05/2010 Titulares: Universidad de Granada y Fundación FIBAO Número de solicitud: P201030791 Resumen: La presente invención se refiere al uso de un ...
-
Biomarkers of environmental, physical and chemical exposure
-
Cancer epidemiology
-
Cell models and molecular mechanisms of tumour control
-
Cell survival and viability analysis
-
Clinical activity in anti-ageing medicine and sports medicine
-
Clinical trials (diagnostic and treatment)
-
Community intervention programmes for correct neuropsychological development in children
-
Cultures and co-cultures of human cells of different types (intestinal, liver, dendritic, preadipocytic).
-
Application number: P201830169 (international PCT/ES2020/070168) and P201930213Application date: 23/02/2018 (international 09/03/2020) and 08/03/2019Holding entities: University of Granada and Servicio Andaluz ...
-
Application Number: P202130793Date of application: 13/08/2021Holding entities: University of Granada, Progreso y Salud Foundation and Andalusian Health Service.
-
The present invention bases on the two enantiómeros of the compound (RS)-9-[1-(p-nitrobencénsulfonil)-1,2,3,5-tetrahidro-4,1-benzoxazepin-3-il]-2,6-dicloro-9H-purina (ACG-812bF3), which disable EGFR (recipient of ...
RSS
